News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,252 Results
Type
Article (39306)
Company Profile (284)
Press Release (648662)
Section
Business (203958)
Career Advice (1997)
Deals (35382)
Drug Delivery (92)
Drug Development (80985)
Employer Resources (168)
FDA (16110)
Job Trends (14816)
News (344802)
Policy (32509)
Tag
Academia (2536)
Alliances (49196)
Alzheimer's disease (1262)
Approvals (16072)
Artificial intelligence (146)
Bankruptcy (352)
Best Places to Work (11588)
Biotechnology (201)
Breast cancer (190)
Cancer (1379)
Cardiovascular disease (110)
Career advice (1665)
Cell therapy (282)
Clinical research (64753)
Collaboration (487)
Compensation (263)
COVID-19 (2625)
C-suite (110)
Data (1394)
Diabetes (177)
Diagnostics (6172)
Earnings (84907)
Employer resources (146)
Events (110031)
Executive appointments (397)
FDA (16798)
Funding (432)
Gene therapy (195)
GLP-1 (601)
Government (4368)
Healthcare (18710)
Infectious disease (2720)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16352)
Job creations (3626)
Job search strategy (1419)
Layoffs (419)
Legal (7873)
Lung cancer (199)
Manufacturing (210)
Medical device (13214)
Medtech (13219)
Mergers & acquisitions (19202)
Metabolic disorders (463)
Neuroscience (1585)
NextGen Class of 2024 (6502)
Non-profit (4467)
Northern California (1702)
Obesity (263)
Opinion (183)
Parkinson's disease (98)
Patents (122)
People (56485)
Phase I (20142)
Phase II (28521)
Phase III (21267)
Pipeline (516)
Postmarket research (2561)
Preclinical (8548)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5892)
Regulatory (21700)
Research institute (2315)
Resumes & cover letters (349)
Southern California (1471)
Startups (3567)
United States (15260)
Vaccines (606)
Weight loss (184)
Date
Today (31)
Last 7 days (505)
Last 30 days (2408)
Last 365 days (35346)
2024 (35189)
2023 (40091)
2022 (51203)
2021 (55764)
2020 (54126)
2019 (46546)
2018 (35023)
2017 (32120)
2016 (31486)
2015 (37553)
2014 (31318)
2013 (26349)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (716)
Arizona (196)
Asia (37290)
Australia (6089)
California (3837)
Canada (1460)
China (309)
Colorado (173)
Connecticut (178)
Europe (79873)
Florida (538)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (635)
Massachusetts (2979)
Michigan (175)
Minnesota (292)
New Jersey (1108)
New York (1095)
North Carolina (744)
Northern California (1702)
Ohio (146)
Pennsylvania (930)
South America (1093)
Southern California (1471)
Texas (555)
Utah (108)
Washington State (401)
688,252 Results for "moderna inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
RSV
FDA Committee Calls For More Research After Moderna’s RSV Vaccine Safety Issues
Following news of RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines, FDA advisors said the trial investigators should continue the study, while keeping an eye out for further safety signals.
December 13, 2024
·
3 min read
·
Tristan Manalac
Job Creations
Massachusetts Tax Incentives for Moderna, Vertex and More Creating 1,155 Jobs
Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in Massachusetts. Moderna and Vertex received the largest awards and will add over 600 combined jobs.
October 24, 2024
·
4 min read
·
Angela Gabriel
Earnings
Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, but RSV Shot Disappoints
While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday note to investors said sales of the company’s respiratory syncytial virus vaccine mRESVIA was significantly lower than expected.
November 7, 2024
·
3 min read
·
Tristan Manalac
Patents
GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and respiratory syncytial virus shot mResvia.
October 16, 2024
·
2 min read
·
Tristan Manalac
Drug Development
Facing ‘Daunting’ Launch Schedule, Moderna to Slash $4B in R&D Spend by 2028
Analysts expressed skepticism about plans detailed by Moderna’s R&D chief Stephen Hoge to trim research spending in preparation for the launch of up to 10 new products.
September 13, 2024
·
4 min read
·
Annalee Armstrong
COVID-19
FDA Greenlights Updated COVID-19 Shots from Pfizer, Moderna for Fall Season
The regulator on Thursday said the mRNA vaccines, Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, will better protect against currently circulating variants as COVID continues to surge in many parts of the U.S.
August 23, 2024
·
2 min read
·
Tristan Manalac
News
Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
September 30, 2024
·
4 min read
Drug Development
Moderna’s COVID-Flu Combo Shot Beats Separate Vaccines in Phase III Study
Moderna’s combination vaccine candidate for COVID-19 and influenza outperformed licensed vaccines in older adults, according to late-stage results reported on Monday.
June 10, 2024
·
2 min read
·
Tristan Manalac
Business
Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program
Blackstone announced a new collaboration with Moderna, Inc. through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences will provide up to $750 million to fund Moderna’s influenza program.
March 27, 2024
·
2 min read
Genetown
Moderna to Present at Upcoming Conferences in May/June 2024
Moderna, Inc., announced its participation in the following upcoming investor conferences:
May 13, 2024
·
1 min read
1 of 68,826
Next
